Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
RECURSION PHARMACEUTICALS-A
About RXRX
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.
Find out what a historical investment in RECURSION PHARMACEUTICALS-A would be worth today using our RXRX stock calculator.
Market Capitalisation
$1.67B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
13.5M
High today
$3.15
Low today
$3.05
Open price
$3.12
52-week high
$7.18
52-week low
$2.80
Ready to start your investing journey with Stake?
Open an accountHow do I buy RXRX shares in Australia?
Buying RXRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in RECURSION PHARMACEUTICALS-A in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RXRX
What is the ticker symbol of RECURSION PHARMACEUTICALS-A?
The ticker symbol for RECURSION PHARMACEUTICALS-A is RXRX.
How much is one share of RXRX?
One share of RXRX is valued at $3.06 as of 13 May 2026.
What is the market capitalisation of RECURSION PHARMACEUTICALS-A RXRX?
As of 13 May 2026 RECURSION PHARMACEUTICALS-A has a market cap of $1.67B.
What is the 52-week high for RECURSION PHARMACEUTICALS-A stock?
The RECURSION PHARMACEUTICALS-A 52-week high stock price is $7.18.
What is the 52-week low for RECURSION PHARMACEUTICALS-A stock?
The RECURSION PHARMACEUTICALS-A 52-week low stock price is $2.80.
Can I buy RXRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RXRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RXRX on Stake
- Buy RXRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RXRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RXRX related stocks